RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Technical University of Munich